These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31883284)

  • 1. Successful parathyroidectomy with intra-operative parathyroid hormone monitoring in a neonate with severe primary hyperparathyroidism caused by homozygous mutation in CASR gene.
    Sorapipatcharoen K; Mahachoklertwattana P; Tim-Aroon T; Wattanasirichaigoon D; Karanes S; Molagool S; Poomthavorn P
    J Paediatr Child Health; 2020 Jul; 56(7):1144-1146. PubMed ID: 31883284
    [No Abstract]   [Full Text] [Related]  

  • 2. Subtotal Parathyroidectomy Successfully Controls Calcium Levels of Patients with Neonatal Severe Hyperparathyroidism Carrying a Novel CASR Mutation.
    Wejaphikul K; Dejkhamron P; Khorana J; Watcharachan K; Intachai W; Olsen B; Tongsima S; Ketudat Cairns JR; Ngamphiw C; Kantaputra P
    Horm Res Paediatr; 2023; 96(4):432-438. PubMed ID: 36626889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal Severe Hyperparathyroidism: Novel Insights From Calcium, PTH, and the CASR Gene.
    Marx SJ; Sinaii N
    J Clin Endocrinol Metab; 2020 Apr; 105(4):1061-78. PubMed ID: 31778168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficiency of cinacalcet treatment in delaying parathyroidectomy in a case with neonatal severe hyperparathyroidism caused by homozygous mutation in the CASR gene.
    Özgüç Çömlek F; Demir S; Gürkan H; İnan M; Sezer A; Dilek E; Kökenli F
    Pediatr Endocrinol Diabetes Metab; 2022; 28(2):168-174. PubMed ID: 35399047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraoperative parathyroid hormone monitoring in neonatal severe primary hyperparathyroidism.
    García-García E; Domínguez-Pascual I; Requena-Díaz M; Cabello-Laureano R; Fernández-Pineda I; Sánchez-Martín MJ
    Pediatrics; 2014 Oct; 134(4):e1203-5. PubMed ID: 25180273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report: acute clinical presentation and neonatal management of primary hyperparathyroidism due to a novel CaSR mutation.
    Capozza M; Chinellato I; Guarnieri V; Di Lorgi N; Accadia M; Traggiai C; Mattioli G; Di Mauro A; Laforgia N
    BMC Pediatr; 2018 Oct; 18(1):340. PubMed ID: 30376845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mutation in the calcium sensing receptor gene in a neonate with severe hyperparathyroidism.
    Kahvecioglu D; Atasay B; Berberoglu M; Yildiz D; Cakir U; Akduman H; Erdeve O; Siklar Z; Magdelaine C; Lienhardt-Roussie A; Akar M; Ozbek MN; Arsan S
    Genet Couns; 2014; 25(3):331-5. PubMed ID: 25365856
    [No Abstract]   [Full Text] [Related]  

  • 8. A Case of Neonatal Severe Hyperparathyroidism: Challenges in Management.
    Gupta P; Tak SA; S AV; Misgar RA; Agarwala S; Jain V; Sharma R
    Indian J Pediatr; 2022 Oct; 89(10):1025-1027. PubMed ID: 35380381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focused parathyroidectomy without intra-operative parathyroid hormone monitoring for primary hyperparathyroidism: results in a low-volume hospital.
    Chow TL; Choi CY; Lam SH
    J Laryngol Otol; 2015 Aug; 129(8):788-94. PubMed ID: 26072937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful parathyroidectomy guided by intraoperative parathyroid hormone monitoring for primary hyperparathyroidism is preserved in mild and moderate renal insufficiency.
    Marcadis AR; Teo R; Ouyang W; Farrá JC; Lew JI
    Surgery; 2018 Mar; 163(3):633-637. PubMed ID: 29273178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cinacalcet as a First-Line Treatment in Neonatal Severe Hyperparathyroidism Secondary to Calcium Sensing Receptor (CaSR) Mutation.
    Gulcan-Kersin S; Kirkgoz T; Eltan M; Rzayev T; Ata P; Bilgen H; Ozek E; Bereket A; Turan S
    Horm Res Paediatr; 2020; 93(5):313-321. PubMed ID: 33147586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel homozygous inactivating mutation of the calcium-sensing receptor gene in neonatal severe hyperparathyroidism responding to cinacalcet therapy: A case report and literature review.
    Sun X; Huang L; Wu J; Tao Y; Yang F
    Medicine (Baltimore); 2018 Nov; 97(45):e13128. PubMed ID: 30407334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal severe hyperparathyroidism: further clinical and molecular delineation.
    Al-Khalaf FA; Ismail A; Soliman AT; Cole DE; Ben-Omran T
    Eur J Pediatr; 2011 May; 170(5):625-31. PubMed ID: 20972686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A homozygous inactivating calcium-sensing receptor mutation, Pro339Thr, is associated with isolated primary hyperparathyroidism: correlation between location of mutations and severity of hypercalcaemia.
    Hannan FM; Nesbit MA; Christie PT; Lissens W; Van der Schueren B; Bex M; Bouillon R; Thakker RV
    Clin Endocrinol (Oxf); 2010 Dec; 73(6):715-22. PubMed ID: 20846291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent findings in the use of intraoperative parathyroid hormone monitoring in parathyroid disease.
    Carneiro-Pla D
    Curr Opin Oncol; 2009 Jan; 21(1):18-22. PubMed ID: 19291832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal severe hyperparathyroidism caused by homozygous mutation in CASR: A rare cause of life-threatening hypercalcemia.
    Murphy H; Patrick J; Báez-Irizarry E; Lacassie Y; Gómez R; Vargas A; Barkemeyer B; Kanotra S; Zambrano RM
    Eur J Med Genet; 2016 Apr; 59(4):227-31. PubMed ID: 26855056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of concurrent chronic kidney disease on intraoperative parathyroid hormone monitoring during parathyroidectomy for primary hyperparathyroidism.
    Sunkara B; Cohen MS; Miller BS; Gauger PG; Hughes DT
    Surgery; 2018 Jan; 163(1):42-47. PubMed ID: 29128188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is intraoperative parathyroid hormone monitoring necessary for primary hyperparathyroidism with concordant preoperative imaging?
    Bobanga ID; McHenry CR
    Am J Surg; 2017 Mar; 213(3):484-488. PubMed ID: 28017299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary hyperparathyroidism and familial hypocalciuric hypercalcemia: relationships and clinical implications.
    Eldeiry LS; Ruan DT; Brown EM; Gaglia JL; Garber JR
    Endocr Pract; 2012; 18(3):412-7. PubMed ID: 22232026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary hyperparathyroidism in a patient with familial hypocalciuric hypercalcaemia due to a novel mutation in the calcium-sensing receptor gene.
    Egan AM; Ryan J; Aziz MA; O'Dwyer TP; Byrne MM
    J Bone Miner Metab; 2013 Jul; 31(4):477-80. PubMed ID: 23081733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.